RxDoctor Payments Data

Susamma Pappachan, NP

Family · Loveland, OHNPI 1558718197

Payments from drug & device makers

$872in general payments, 2019–2025

Across 48 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$274
  • Supernus Pharmaceuticals, Inc.$106
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$83
  • Exact Sciences$59
  • Bayer$44
  • Organon$43
  • plus $263 from 12 others

What the payments were for

  • Food & beverage$872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$872 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$1,710
Medicare patients
31
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide61$72,772
FarxigaDapagliflozin Propanediol27$32,362
OzempicSemaglutide31$31,065
JardianceEmpagliflozin16$28,016
MounjaroTirzepatide13$16,737
Spiriva RespimatTiotropium Bromide16$12,481
DuleraMometasone/Formoterol27$9,729
Incruse ElliptaUmeclidinium Bromide19$8,510
SymbicortBudesonide/Formoterol Fumarate27$6,303
Albuterol Sulfate HfaAlbuterol Sulfate98$2,013
Prazosin Hcl13$1,802
Atorvastatin Calcium160$953
Metformin Hcl48$551
Levothyroxine Sodium58$531
Hydroxyzine Hcl11$488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$16$89,50974 claims
AstraZenecaFarxiga, Symbicort$20$38,66554 claims
GSKIncruse Ellipta$19$8,51019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in Loveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →